Quality products?make an important contribution to long-term revenue and profitability. Good factory exports good OPC-67683 681492-22-8

1.What is the OPC-67683 ?

Marketed by Otsuka, delamanid was approved in both the European Union and Japan in 2014 as part of combination therapies for multi-drug resistant tuberculosis (TB). Because delamanid exhibited no adverse drug–drug interactions, it has found utility as a combination therapy with standard antiretroviral drugs indicated for TB. Delamanid blocks mycolic acid biosynthesis in Mycobacterium tuberculosis, which allows its cell wall to be penetrated by small molecule antivirals.

2.What is the CAS number for OPC-67683 ?

The CAS number of OPC-67683 is 681492-22-8.

3.What are another words for OPC-67683 ?

Synonyms?for?OPC-67683 681492-22-8:Delamanid; UNII-8OOT6M1PC7

4.What is OPC-67683 (681492-22-8) used for?

Delamanid is a novel anti-tuberculosis medication that inhibits mycolic acid synthesis and shows potent in vitro and in vivo activity against drug-resistant strains of Mycobacterium tuberculosis.

Relevant articles related to OPC-67683:

5.Buy OPC-67683 with the best price .

Hangzhou B&P Biotech Co,.Ltd is a quality supplier of OPC-67683. Our main goal is customer satisfaction. Contact us to negotiate the best price for your business on OPC-67683 681492-22-8.